 |
Back to top Hypothermic Techniques: When and WherePresented by Stephan A. Mayer, MD
There is probably no clinical condition in medicine today which engenders a more overwhelming sense of clinical nihilism than hypoxic-ischemic coma. The role of the clinician in managing these patients has, until very recently, been restricted to prognostication, and little else. Fortunately, with the advent of early induced hypothermia, which is now feasible in the critical care environment, this is changing.
Late-Breaking Clinical Trials and Trial Updates: Novel Therapies for Acute Myocardial InfarctionPresented by Gregg W. Stone, MD, F.A.C.C.
William W. O’Neill, MD, F.A.C.C.
Menko Jan de Boer, MD, F.A.C.C.
Dan Tzivoni, MD, F.A.C.C.
Michel R. LeMay, MD, F.A.C.C.
Tomasz Siminiak, MD, Ph.D., F.A.C.C.
This summary highlights key data from the EMERALD, AMIHOT, On-Time, CAPITAL AMI, and POZNAN trials.
Patients at Risk for Recurrent Embolism After Percutaneous Closure of Patent Foramen Ovale for Presumed Paradoxical EmbolismPresented by Markus Schwerzmann, MD
Risk for recurrent embolic events after percutaneous closure of patent foramen ovale (PFO) was increased in patients with multiple cardiovascular risk factors, and in patients with 2 or more thromboembolic events prior to device implantation. These findings may help elucidate which patients are at low risk for recurrent events after PFO closure, and therefore benefit most from percutaneous PFO closure.
Urinary Tract Infection in Patients with Acute Coronary syndrome: A Potential Systemic connectionPresented by John B. Sims, MD
In patients with acute coronary syndromes, subclinical urinary tract infections (UTIs) are more common than in a group of patients awaiting bypass surgery, results of this retrospective, case-control study suggest. Subclinical infection may be a trigger for ACS, perhaps via activation of systemic inflammation.
|
|
|
